Christian Trepo，里昂，法国——HBV相关实验室及人物介绍系列

bigben446

Christian Trepo，里昂，法国——HBV相关实验室及人物介绍系列

Christian Trepo，里昂, 法国
法国研究HBV常青树

Petit, M. A. and P. Berthillon, et al. (2015). "Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases." Clin Res Hepatol Gastroenterol 39(6): 699-704.
Lucifora, J. and C. Trepo (2015). "Hepatitis: After HCV cure, HBV cure?" Nat Rev Gastroenterol Hepatol 12(7): 376-8.
Trepo, C. (2014). "A brief history of hepatitis milestones." Liver Int 34 Suppl 1: 29-37.
Arnaud, C. and C. Trepo, et al. (2014). "Predictors of the therapeutic response in hepatitis C. A 2013 update." Clin Res Hepatol Gastroenterol 38(1): 12-7.
Trepo, C. and H. L. Chan, et al. (2014). "Hepatitis B virus infection." Lancet 384(9959): 2053-63.
Martel, N. and S. A. Gomes, et al. (2013). "Improved rolling circle amplification (RCA) of hepatitis B virus (HBV) relaxed-circular serum DNA (RC-DNA)." J Virol Methods 193(2): 653-9.
Dupinay, T. and T. Gheit, et al. (2013). "Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island." Hepatology 58(5): 1610-20.
Arnaud, C. and P. Pradat, et al. (2013). "Pretreatment predictive factors for hepatitis C therapy outcome: relevance of anti-E1E2 antibodies compared to IP-10 and IL28B genotypes." Antivir Ther 18(8): 1027-32.
Martel, N. and L. Cotte, et al. (2012). "Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape." J Infect Dis 205(11): 1757-61.
Scholtes, C. and P. Andre, et al. (2012). "Farnesoid X receptor targeting for hepatitis C: study protocol for a proof-of-concept trial." Therapie 67(5): 423-7.
Ndongo-Thiam, N. and P. Berthillon, et al. (2011). "Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes." Hepatology 54(2): 406-17.
Franceschi, S. and M. Lise, et al. (2011). "Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC)." Cancer Epidemiol Biomarkers Prev 20(1): 208-14.
Vincent, I. E. and C. Zannetti, et al. (2011). "Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic  cells." PLoS One 6(10): e26315.
Galy, O. and I. Chemin, et al. (2011). "Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand." Hepat Res Treat 2011: 697162.
Sahajian, F. and F. Bailly, et al. (2011). "A randomized trial of viral hepatitis prevention among underprivileged people in  the Lyon area of France." J Public Health (Oxf) 33(2): 182-92.
Ndongo, N. and S. Selliah, et al. (2011). "Expression of E1E2 on hepatitis C RNA-containing particles released from primary  cultured human hepatocytes derived from infected cirrhotic livers." Intervirology 54(1): 1-9.
Ndongo, N. and P. Berthillon, et al. (2010). "Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral  response to therapy in patients infected with hepatitis C virus." Hepatology 52(5): 1531-42.
Bailly, F. and S. N. Ahmed, et al. (2010). "Management of nonresponsive hepatitis C." Expert Rev Anti Infect Ther 8(4): 379-95.
Lucifora, J. and I. E. Vincent, et al. (2010). "Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model." Hepatology 51(6): 1954-60.
Faurie, P. and C. Broussolle, et al. (2010). "Sarcoidosis and hepatitis C: clinical description of 11 cases." Eur J Gastroenterol Hepatol 22(8): 967-72.
Trepo, C. and F. Bailly (2010). "Maintenance ribavirin monotherapy: the case for post-transplantation recurrent hepatitis C." Dig Liver Dis 42(4): 283-4.
Dufour, J. F. and P. Pradat, et al. (2009). "Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases." Eur J Gastroenterol Hepatol 21(3): 245-53.
Trepo, C. and P. Pradat (2009). "Hepatitis C: CIFN for re-treatment of PEG-IFN plus RBV nonresponders?" Nat Rev Gastroenterol Hepatol 6(10): 570-1.
Trepo, C. and F. Zoulim (2009). "[Treatment of hepatitis B: new perspectives]." Gastroenterol Clin Biol 33(8-9): 811-7.
Borgniet, O. and P. Parvaz, et al. (2009). "Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy  for chronic hepatitis B." J Med Virol 81(8): 1336-42.
Vincent, I. E. and J. Lucifora, et al. (2009). "Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro." Antivir Ther 14(1): 131-5.
Chossegros, P. and P. Melin, et al. (2008). "A French prospective observational study of the treatment of chronic hepatitis C  in drug abusers." Gastroenterol Clin Biol 32(10): 850-7.
Maynard, M. and P. Pradat, et al. (2008). "Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients." Antivir Ther 13(4): 607-11.
Margeridon, S. and S. Carrouee-Durantel, et al. (2008). "Rolling circle amplification, a powerful tool for genetic and functional studies  of complete hepatitis B virus genomes from low-level infections and for directly  probing covalently closed circular DNA." Antimicrob Agents Chemother 52(9): 3068-73.
Carrouee-Durantel, S. and D. Durantel, et al. (2008). "Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants." Antivir Ther 13(3): 381-8.
Thermet, A. and T. Buronfosse, et al. (2008). "DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection." J Gen Virol 89(Pt 5): 1192-201.
Villet, S. and C. Pichoud, et al. (2008). "Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure." J Hepatol 48(5): 747-55.
Trepo, C. and A. M. Marion-Audibert, et al. (2007). "[Maintenance therapy for chronic hepatitis C]." Gastroenterol Clin Biol 31(8-9 Pt 3): 4S29-33.
Benet, T. and A. J. D'Oliveira, et al. (2007). "Characteristics and survival of HIV-infected patients not screened for hepatitis  C virus infection in a hospital-based cohort." J Viral Hepat 14(10): 730-5.
Miailhes, P. and M. A. Trabaud, et al. (2007). "Impact of highly active antiretroviral therapy (HAART) on the natural history of  hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion." Clin Infect Dis 45(5): 624-32.
Pradat, P. and H. L. Tillmann, et al. (2007). "Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications." J Viral Hepat 14(8): 556-63.
Mrani, S. and I. Chemin, et al. (2007). "Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C." J Med Virol 79(8): 1075-81.
Souvignet, C. and O. Lejeune, et al. (2007). "Interferon-based treatment of chronic hepatitis C." Biochimie 89(6-7): 894-8.
Chapel, C. and C. Garcia, et al. (2007). "Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors." J Gen Virol 88(Pt 4): 1133-43.
Brunelle, M. N. and J. Lucifora, et al. (2007). "In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants." Antimicrob Agents Chemother 51(6): 2240-3.
Pradat, P. and N. Voirin, et al. (2007). "Progression to cirrhosis in hepatitis C patients: an age-dependent process." Liver Int 27(3): 335-9.
Villet, S. and A. Ollivet, et al. (2007). "Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient." J Hepatol 46(3): 531-8.
Bizollon, T. and P. Pradat, et al. (2007). "Histological benefit of retreatment by pegylated interferon alfa-2b and ribavirin in patients with recurrent hepatitis C virus infection posttransplantation." Am J Transplant 7(2): 448-53.
Combet, C. and N. Garnier, et al. (2007). "euHCVdb: the European hepatitis C virus database." Nucleic Acids Res 35(Database issue): D363-6.
Belot, A. and B. Ranchin, et al. (2007). "Hypertensive crisis, hepatitis B virus and polyarteritis nodosa in a child." Pediatr Nephrol 22(1): 97-100.
Sahajian, F. and P. Vanhems, et al. (2007). "Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France." Eur J Public Health 17(3): 263-71.
Galy, O. and M. A. Petit, et al. (2007). "Efficient hepatitis C antigen immunohistological staining in sections of normal,  cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins." Cancer Lett 248(1): 81-8.
Zoulim, F. and T. Poynard, et al. (2006). "A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine." J Viral Hepat 13(4): 278-88.
Chapel, C. and C. Garcia, et al. (2006). "Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles." J Gen Virol 87(Pt 4): 861-71.
Jacquard, A. C. and M. N. Brunelle, et al. (2006). "In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine." Antimicrob Agents Chemother 50(3): 955-61.
Fournillier, A. and P. Dupeyrot, et al. (2006). "Primary and memory T cell responses induced by hepatitis C virus multiepitope long peptides." Vaccine 24(16): 3153-64.
Maynard, M. and P. Pradat, et al. (2006). "Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI)." J Hepatol 44(3): 484-90.
Narayan, R. and T. Buronfosse, et al. (2006). "Rise in gamma interferon expression during resolution of duck hepatitis B virus infection." J Gen Virol 87(Pt 11): 3225-32.
Escuret, V. and A. Martin, et al. (2006). "Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy  in a subgenomic replicon system." Antimicrob Agents Chemother 50(12): 3984-91.
Villet, S. and C. Pichoud, et al. (2006). "Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient." Gastroenterology 131(4): 1253-61.
Diaz, O. and F. Delers, et al. (2006). "Preferential association of Hepatitis C virus with apolipoprotein B48-containing  lipoproteins." J Gen Virol 87(Pt 10): 2983-91.
Martin, P. and P. Parroche, et al. (2006). "Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein." Microbes Infect 8(9-10): 2432-41.
Durantel, D. and M. N. Brunelle, et al. (2005). "Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing." J Clin Virol 34 Suppl 1: S34-43.
Bizollon, T. and P. Pradat, et al. (2005). "Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C." Am J Transplant 5(8): 1909-13.
Margeridon, S. and A. Lachaux, et al. (2005). "A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus." J Gen Virol 86(Pt 6): 1687-93.
Khattab, E. and I. Chemin, et al. (2005). "Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy." J Clin Virol 33(2): 150-7.
Petit, M. A. and M. Lievre, et al. (2005). "Enveloped particles in the serum of chronic hepatitis C patients." Virology 336(2): 144-53.
Nissen, M. J. and E. Fontanges, et al. (2005). "Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon." Rheumatology (Oxford) 44(8): 1016-20.
D'Oliveira, A. J. and N. Voirin, et al. (2005). "Prevalence and sexual risk of hepatitis C virus infection when human immunodeficiency virus was acquired through sexual intercourse among patients of  the Lyon University Hospitals, France, 1992-2002." J Viral Hepat 12(3): 330-2.
Bizollon, T. and M. Adham, et al. (2005). "Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C." Transplantation 79(3): 325-9.
Robaczewska, M. and R. Narayan, et al. (2005). "Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA)." J Hepatol 42(2): 180-7.
Fournillier, A. and D. Freida, et al. (2004). "Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus." J Med Virol 72(4): 566-74.
Thermet, A. and M. Robaczewska, et al. (2004). "Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection." J Virol 78(4): 1945-53.
Werle, B. and K. Cinquin, et al. (2004). "Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy." J Viral Hepat 11(1): 74-83.
Rocca, P. and L. Codes, et al. (2004). "[Autoimmunization induced by interferon alpha therapy in chronic hepatitis C]." Gastroenterol Clin Biol 28(11): 1173-6.
Sahajian, F. and G. Excler, et al. (2004). "Hepatitis C screening practices among private practitioners: impact of an information campaign." Gastroenterol Clin Biol 28(8-9): 714-9.
Seve, P. and P. Renaudier, et al. (2004). "Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional  study in Lyon, France." Eur J Gastroenterol Hepatol 16(12): 1361-5.
Voirin, N. and C. Trepo, et al. (2004). "Survival in HIV-infected patients is associated with hepatitis C virus infection  and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database." J Viral Hepat 11(6): 559-62.
Durantel, D. and S. Carrouee-Durantel, et al. (2004). "A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus." Hepatology 40(4): 855-64.
Martin, P. and P. Parroche, et al. (2004). "Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic  mice lead to the identification of three novel epitopes in hepatitis C virus NS3  antigen." J Med Virol 74(3): 397-405.
Bain, C. and P. Parroche, et al. (2004). "Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection." J Virol 78(19): 10460-9.
Vuillermoz, I. and E. Khattab, et al. (2004). "Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy." J Med Virol 74(1): 41-53.
Jeantet, D. and I. Chemin, et al. (2004). "Cloning and expression of surface antigens from occult chronic hepatitis B virus  infections and their recognition by commercial detection assays." J Med Virol 73(4): 508-15.
Jacquard, A. C. and M. Nassal, et al. (2004). "Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection." Antimicrob Agents Chemother 48(7): 2683-92.
Werle-Lapostolle, B. and S. Bowden, et al. (2004). "Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy." Gastroenterology 126(7): 1750-8.
Pradat, P. and M. Maynard, et al. (2004). "The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment." J Med Virol 73(3): 392-6.
Merle, P. and M. H. Elghouzzi, et al. (2004). "[Hepatitis G virus and labile blood products: role of transfusional transmission]." Transfus Clin Biol 11(2): 75-80.
Goutagny, N. and C. Vieux, et al. (2004). "Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection." J Infect Dis 189(9): 1646-55.
Trepo, C. and M. Maynard, et al. (2003). "Perspectives on therapy of hepatitis B." J Hepatol 39 Suppl 1: S220-3.
Favre, D. and M. A. Petit, et al. (2003). "Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro." ALTEX 20(3): 131-42.
Petit, M. A. and C. Jolivet-Reynaud, et al. (2003). "Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope." J Biol Chem 278(45): 44385-92.
Maynard, M. and P. Pradat, et al. (2003). "Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy." J Viral Hepat 10(4): 318-23.
Seigneres, B. and P. Martin, et al. (2003). "Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model." Antimicrob Agents Chemother 47(6): 1842-52.
Rocca, P. and F. Bailly, et al. (2003). "[Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients]." Gastroenterol Clin Biol 27(3 Pt 1): 294-9.
Le Guerhier, F. and A. Thermet, et al. (2003). "Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model." J Hepatol 38(3): 328-34.
Bizollon, T. and S. N. Ahmed, et al. (2003). "Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence." Gut 52(2): 283-7.
Thermet, A. and C. Rollier, et al. (2003). "Progress in DNA vaccine for prophylaxis and therapy of hepatitis B." Vaccine 21(7-8): 659-62.
Zoulim, F. and M. Chevallier, et al. (2003). "Clinical consequences of hepatitis C virus infection." Rev Med Virol 13(1): 57-68.
Pradat, P. and A. Alberti, et al. (2002). "Predictive value of ALT levels for histologic findings in chronic hepatitis C: a  European collaborative study." Hepatology 36(4 Pt 1): 973-7.
Voirin, N. and C. Trepo, et al. (2002). "Effects of co-infection with hepatitis C virus and GB virus C on CD4 cell count and HIV-RNA level among HIV-infected patients treated with highly active antiretroviral therapy." AIDS 16(11): 1556-9.
Gheit, T. and S. Sekkat, et al. (2002). "Experimental transfection of Macaca sylvanus with cloned human hepatitis B virus." J Gen Virol 83(Pt 7): 1645-9.
Favre, D. and P. Berthillon, et al. (2002). "[In vitro hepatitis C. Elimination of lipoproteins associated with cells: an important stage to obtain an efficient infection of human hepatocytes by the hepatitis C virus]." Rev Med Suisse Romande 122(4): 205.
Jeantet, D. and I. Chemin, et al. (2002). "Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient." Hepatology 35(5): 1215-24.
Delmas, J. and O. Schorr, et al. (2002). "Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro." Antimicrob Agents Chemother 46(2): 425-33.
Colin, C. and D. Lanoir, et al. (2001). "Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature." J Viral Hepat 8(2): 87-95.
Le Guerhier, F. and C. Pichoud, et al. (2001). "Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus." Antimicrob Agents Chemother 45(4): 1065-77.
Seigneres, B. and S. Aguesse-Germon, et al. (2001). "Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo." J Hepatol 34(1): 114-22.
Bain, C. and A. Fatmi, et al. (2001). "Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection." Gastroenterology 120(2): 512-24.
Favre, D. and P. Berthillon, et al. (2001). "Removal of cell-bound lipoproteins: a crucial step for the efficient infection of liver cells with hepatitis C virus in vitro." C R Acad Sci III 324(12): 1141-8.
Merle, P. and C. Trepo, et al. (2001). "Current management strategies for hepatitis B in the elderly." Drugs Aging 18(10): 725-35.
Merle, P. and C. Trepo (2001). "Therapeutic management of hepatitis B-related cirrhosis." J Viral Hepat 8(6): 391-9.
Chemin, I. and D. Jeantet, et al. (2001). "Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver  disease." Antiviral Res 52(2): 117-23.
Pradat, P. and E. Caillat-Vallet, et al. (2001). "Prevalence of hepatitis C infection among general practice patients in the Lyon area, France." Eur J Epidemiol 17(1): 47-51.
Borel, C. and O. Schorr, et al. (2001). "Initial amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of embryonic duck hepatocytes is increased by cell cycle progression." Hepatology 34(1): 168-79.
Sahajian, F. and F. Bailly, et al. (2001). "[Medical follow-up of patients with positive serology for hepatitis C virus]." Gastroenterol Clin Biol 25(3): 262-7.
Merle, P. and M. Chevallier, et al. (2001). "Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice." J Hepatol 34(4): 562-9.
Chemin, I. and F. Zoulim, et al. (2001). "High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology." J Hepatol 34(3): 447-54.
Querenghi, F. and Q. Yu, et al. (2001). "Evolution of hepatitis C virus genome in chronically infected patients receiving  ribavirin monotherapy." J Viral Hepat 8(2): 120-31.
Trepo, C. and S. N. Ahmed, et al. (2000). "Treatment of chronic hepatitis C with interferon in combination with other compounds." Acta Gastroenterol Belg 63(2): 204-6.
Touzet, S. and L. Kraemer, et al. (2000). "Epidemiology of hepatitis C virus infection in seven European Union countries: a  critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research." Eur J Gastroenterol Hepatol 12(6): 667-78.
Trepo, C. (2000). "Genotype and viral load as prognostic indicators in the treatment of hepatitis C." J Viral Hepat 7(4): 250-7.
Trepo, C. and P. Jezek, et al. (2000). "Famciclovir in chronic hepatitis B: results of a dose-finding study." J Hepatol 32(6): 1011-8.
Pradat, P. and P. Chossegros, et al. (2000). "Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy." J Viral Hepat 7(3): 203-10.
Seigneres, B. and C. Pichoud, et al. (2000). "Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B." J Infect Dis 181(4): 1221-33.
Pichoud, C. and F. Berby, et al. (2000). "Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B." J Hepatol 32(2): 307-16.
Habersetzer, F. and N. Boyer, et al. (2000). "A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C." Liver 20(6): 437-41.
Nafa, S. and S. Ahmed, et al. (2000). "Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B." Hepatology 32(5): 1078-88.
Vidalin, O. and A. Fournillier, et al. (2000). "Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens." Virology 276(2): 259-70.
Bizollon, T. and S. N. Ahmed, et al. (2000). "Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence  and its severity in liver transplant patients." Gut 47(5): 698-702.
Grandjacques, C. and P. Pradat, et al. (2000). "Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity." J Hepatol 33(3): 430-9.
Le Guerhier, F. and C. Pichoud, et al. (2000). "Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model." Antimicrob Agents Chemother 44(1): 111-22.
Barraud, L. and S. Guerret, et al. (1999). "Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure." Hepatology 29(4): 1317-23.
Bizollon, T. and C. Ducerf, et al. (1999). "Hepatitis C virus recurrence after liver transplantation." Gut 44(4): 575-8.
Sunyach, C. and C. Rollier, et al. (1999). "Residues critical for duck hepatitis B virus neutralization are involved in host  cell interaction." J Virol 73(4): 2569-75.
Moncharmont, P. and P. Merle, et al. (1999). "[Hepatitis G virus in blood donors]." Presse Med 28(6): 269-72.
Hantz, O. and C. Perigaud, et al. (1999). "The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo." Antiviral Res 40(3): 179-87.
Sahajian, F. and E. Caillat-Vallet, et al. (1999). "[General practice patterns in hepatitis C virus mass screening in the Lyons region]." Sante Publique 11(4): 513-25.
Pichoud, C. and B. Seigneres, et al. (1999). "Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance." Hepatology 29(1): 230-7.
Trepo, C. and P. Pradat (1999). "Hepatitis C virus infection in Western Europe." J Hepatol 31 Suppl 1: 80-3.
Guerret, S. and A. Desmouliere, et al. (1999). "Long-term administration of interferon-alpha in non-responder patients with chronic hepatitis C: follow-up of liver fibrosis over 5 years." J Viral Hepat 6(2): 125-33.
Bizollon, T. and C. Ducerf, et al. (1999). "Treatment of recurrent hepatitis C following liver transplantation." Curr Gastroenterol Rep 1(1): 15-9.
Rumin, S. and P. Berthillon, et al. (1999). "Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro." J Gen Virol 80 ( Pt 11): 3007-18.
Trepo, C. and F. Zoulim, et al. (1999). "Viral hepatitis." Curr Opin Infect Dis 12(5): 481-90.
Broussolle, C. and M. P. Steineur, et al. (1999). "[Hepatitis C virus infection and thyroid diseases]." Rev Med Interne 20(9): 766-73.
Zoulim, F. and C. Trepo (1999). "New antiviral agents for the therapy of chronic hepatitis B virus infection." Intervirology 42(2-3): 125-44.
Romand, F. and M. Michallet, et al. (1999). "[Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B]." Gastroenterol Clin Biol 23(6-7): 770-4.
Vidalin, O. and E. Tanaka, et al. (1999). "Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination." DNA Cell Biol 18(8): 611-21.
Fournillier, A. and E. Depla, et al. (1999). "Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization." J Virol 73(9): 7497-504.
Bizollon, T. and S. Guichard, et al. (1998). "Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation." J Hepatol 29(6): 893-900.
Habersetzer, F. and F. Zoulim, et al. (1998). "Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha." J Viral Hepat 5(6): 407-14.
Thiery, S. and L. Misery, et al. (1998). "[Epidermolysis bullosa acquisita and hepatitis C]." Ann Dermatol Venereol 125(4): 264-7.
Habersetzer, F. and A. Fournillier, et al. (1998). "Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties." Virology 249(1): 32-41.
Langon, T. and S. Fillon, et al. (1998). "Analysis of a hepatitis delta virus isolate from the Central African Republic." Res Virol 149(3): 171-85.
Zoulim, F. and C. Trepo (1998). "Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy." J Hepatol 29(1): 151-68.
Ducret, N. and S. Mercier, et al. (1998). "[National study of screening practices for hepatitis C among hemodialysis patients. Hepatitis Group]." Nephrologie 19(4): 217-22.
Zoulim, F. and J. Haem, et al. (1998). "Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients." J Viral Hepat 5(3): 193-8.
Fournillier, A. and I. Nakano, et al. (1998). "Modulation of immune responses to hepatitis C virus envelope E2 protein following injection of plasmid DNA using single or combined delivery routes." Hepatology 28(1): 237-44.
Lerat, H. and S. Rumin, et al. (1998). "In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype." Blood 91(10): 3841-9.
Inchauspe, G. and M. E. Major, et al. (1998). "Immune responses against hepatitis C virus structural proteins following genetic  immunisation." Dev Biol Stand 92: 163-8.
Aguesse-Germon, S. and S. H. Liu, et al. (1998). "Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication." Antimicrob Agents Chemother 42(2): 369-76.
Langon, T. and C. Pichoud, et al. (1998). "A novel vector for the study of hepatitis delta virus replication." J Virol Methods 70(1): 19-28.
Merle, P. and C. Trepo (1998). "-Vaccination against hepatitis B-." Arch Pediatr 5(3): 326-32.
Inchauspe, G. and L. Vitvitski, et al. (1997). "Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization." DNA Cell Biol 16(2): 185-95.
Vial, T. and M. Biour, et al. (1997). "Antibiotic-associated hepatitis: update from 1990." Ann Pharmacother 31(2): 204-20.
Dumortier, J. and S. Durupt, et al. (1997). "[Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir]." Gastroenterol Clin Biol 21(12): 982-6.
Zoulim, F. and C. Trepo (1997). "[Effects and risks of prolonged antiviral treatments: the example of chronic hepatitis B]." Gastroenterol Clin Biol 21(11): 843-7.
Merle, P. and R. Levy, et al. (1997). "[Efficacy of interferon alpha in primary prevention of preneoplastic lesions in a transgenic murine model of hepatocellular carcinoma related to the interaction between woodchuck hepatitis viruses and c-myc oncogene]." Gastroenterol Clin Biol 21(6-7): 459-65.
Trepo, C. and P. Merle, et al. (1997). "[Treatments of hepatitis C]." Rev Med Interne 18 Suppl 2: 72s-75s.
Trepo, C. (1997). "[Should hepatitis C be screened? Value of hepatitis C screening]." Gastroenterol Clin Biol 21(1 Pt 2): S1-3.
Hantz, O. and C. Borel, et al. (1997). "Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles." Antimicrob Agents Chemother 41(11): 2579-81.
Nakano, I. and G. Maertens, et al. (1997). "Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode." J Virol 71(9): 7101-9.
Sunyach, C. and S. Chassot, et al. (1997). "In vivo selection of duck hepatitis B virus pre-S variants which escape from neutralization." Virology 234(2): 291-9.
Bizollon, T. and U. Palazzo, et al. (1997). "Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation." Hepatology 26(2): 500-4.
Inchauspe, G. and M. E. Major, et al. (1997). "DNA vaccination for the induction of immune responses against hepatitis C virus proteins." Vaccine 15(8): 853-6.
Gouillat, C. and D. Manganas, et al. (1997). "Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma." J Hepatol 26(6): 1324-30.
Colin, C. and P. Vergnon, et al. (1997). "Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study." Eur J Clin Microbiol Infect Dis 16(3): 220-7.
Trabaud, M. A. and F. Bailly, et al. (1997). "Comparison of HCV RNA assays for the detection and quantification of hepatitis C  virus RNA levels in serum of patients with chronic hepatitis C treated with interferon." J Med Virol 52(1): 105-12.
Garnier, J. L. and P. Chossegros, et al. (1997). "Treatment of hepatitis B virus replication by ganciclovir in kidney transplant patients." Transplant Proc 29(1-2): 817.
Garnier, J. L. and P. Chevallier, et al. (1997). "Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients." Transplant Proc 29(1-2): 783.
Bizollon, T. and M. Adahm, et al. (1996). "New approaches to treatment of recurrent hepatitis C virus following liver transplantation using ribavirin." Transplant Proc 28(5): 2842-3.
Vidalin, O. and M. E. Major, et al. (1996). "In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides." Antimicrob Agents Chemother 40(10): 2337-44.
Trabaud, M. A. and F. Bailly, et al. (1996). "Stability of hepatitis C virus RNA in serum from samples collected in a closed-tube system for serum separation and transport, as measured by a quantitative competitive PCR assay." J Viral Hepat 3(4): 207-9.
Berthillon, P. and J. M. Crance, et al. (1996). "Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins  by interferon in a human hepatocarcinoma cell line (PLC/PRF/5)." J Hepatol 25(1): 15-9.
Turin, F. and C. Borel, et al. (1996). "n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis  B virus covalently closed circular DNA after in vitro infection of duck hepatocytes." J Virol 70(5): 2691-6.
Zoulim, F. and X. Zhang, et al. (1996). "Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc." J Hepatol 24(2): 155-60.
Zoulim, F. and E. Dannaoui, et al. (1996). "2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo." Antimicrob Agents Chemother 40(2): 448-53.
Lerat, H. and F. Berby, et al. (1996). "Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells." J Clin Invest 97(3): 845-51.
Trepo, C. and F. Bailly, et al. (1996). "Treatment of chronic hepatitis C: another therapeutic option." Nephrol Dial Transplant 11 Suppl 4: 62-4.
Vergnon, P. and C. Colin, et al. (1996). "[Medical and economic evaluation of donated blood screening for hepatitis C and non-A, non-B, non-C hepatitis]." Rev Epidemiol Sante Publique 44(1): 66-79.
Zhang, X. and F. Zoulim, et al. (1996). "Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B." J Med Virol 48(1): 8-16.
Zoulim, F. and F. Capel, et al. (1995). "[Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B]." Gastroenterol Clin Biol 19(12): 970-5.
Trepo, C. and F. Habersetzer, et al. (1995). "[Treatment of hepatitis C]." Pathol Biol (Paris) 43(8): 716-24.
Major, M. E. and L. Vitvitski, et al. (1995). "DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid." J Virol 69(9): 5798-805.
Duflot, A. and R. Mehrotra, et al. (1995). "Spectrum of liver disease and duck hepatitis B virus infection in a large series  of Chinese ducks with hepatocellular carcinoma." Hepatology 21(6): 1483-91.
Gaudin, J. L. and P. Faure, et al. (1995). "The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial." Liver 15(1): 45-52.
Li, J. S. and S. P. Tong, et al. (1995). "Single-step nested polymerase chain reaction for detection of different genotypes of hepatitis C virus." J Med Virol 45(2): 151-5.
Trepo, C. (1995). "[Hepatitis viruses]." Rev Prat 45(2): 161-7.
Li, J. S. and L. Vitvitski, et al. (1995). "Characterization of the third most common genotype of hepatitis C virus in France." J Hepatol 22(1 Suppl): 74-82.
Lachaux, A. and A. Lapillonne, et al. (1995). "Transplacental transmission of hepatitis B virus: a familial case." Pediatr Infect Dis J 14(1): 60-3.
Zoulim, F. and C. Trepo (1994). "Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications." J Hepatol 21(2): 142-4.
Trepo, C. and F. Habersetzer, et al. (1994). "Interferon therapy for hepatitis C." Antiviral Res 24(2-3): 155-63.
Qu, D. and J. S. Li, et al. (1994). "Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II." J Hepatol 21(1): 70-5.
Alonso, C. and M. L. Pedroso, et al. (1994). "Hepatitis C virus among blood donors: follow-up study." Transfusion 34(6): 527-30.
Qu, D. and O. Hantz, et al. (1994). "Heterogeneity of hepatitis C virus genotypes in France." J Gen Virol 75 ( Pt 5): 1063-70.
Trepo, C. and F. Bailly (1994). "[The biology of the hepatitis C virus]." Ann Gastroenterol Hepatol (Paris) 30(3): 129-31.
Bissuel, F. and F. Bruneel, et al. (1994). "Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy." J Intern Med 235(4): 367-71.
Trepo, C. and C. Alonso, et al. (1994). "[Limits of immunoserologic and molecular diagnosis of hepatitis C]." Nucl Med Biol 21(3): 419-31.
Parvaz, P. and E. Guichard, et al. (1994). "Hepatitis C: description of a highly sensitive method for clinical detection of viral RNA." J Virol Methods 47(1-2): 83-94.
Chassot, S. and V. Lambert, et al. (1994). "Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning." Virology 200(1): 72-8.
Li, J. S. and L. Vitvitski, et al. (1994). "Identification of the third major genotype of hepatitis C virus in France." Biochem Biophys Res Commun 199(3): 1474-81.
Chossegros, P. and P. Chevallier, et al. (1994). "[Cost of acute hepatitis A in adults in France]." Presse Med 23(12): 561-4.
Tang, J. R. and P. Faure, et al. (1994). "Detection of small and large genomes of hepatitis D virus in serum of patients with hepatitis D." J Med Virol 42(1): 1-6.
Cova, L. and R. Mehrotra, et al. (1994). "Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in domestic Chinese ducks." Br J Cancer 69(1): 104-9.
Alonso, C. and D. Qu, et al. (1994). "Serological responses to different genotypes of hepatitis C virus in France." J Clin Microbiol 32(1): 211-2.
Tang, J. R. and L. Cova, et al. (1994). "Clinical relevance of the detection of hepatitis delta virus RNA in serum by RNA  hybridization and polymerase chain reaction." J Hepatol 21(6): 953-60.
Trepo, C. and F. Zoulim, et al. (1993). "Diagnostic markers of viral hepatitis B and C." Gut 34(2 Suppl): S20-5.
Gaudin, J. L. and C. Trepo (1993). "Therapy of chronic delta hepatitis with alpha- and beta-interferon." Prog Clin Biol Res 382: 345-52.
Cova, L. and A. Duflot, et al. (1993). "Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in ducks." Arch Virol Suppl 8: 81-7.
Chassot, S. and V. Lambert, et al. (1993). "Duck hepatitis B virus (DHBV) as a model for understanding hepadnavirus neutralization." Arch Virol Suppl 8: 133-9.
Chassot, S. and V. Lambert, et al. (1993). "Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides." Virology 192(1): 217-23.
Manabe, N. and M. Chevallier, et al. (1993). "Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation." Hepatology 18(6): 1344-9.
Chemin, I. and C. Vermot-Desroches, et al. (1993). "Monitoring of early events of experimental woodchuck hepatitis infection: studies of peripheral blood mononuclear cells by cytofluorometry and PCR." FEMS Immunol Med Microbiol 7(3): 241-9.
Tang, J. R. and O. Hantz, et al. (1993). "Discovery of a novel point mutation changing the HDAg expression of a hepatitis delta virus isolate from Central African Republic." J Gen Virol 74 ( Pt 9): 1827-35.
Li, J. S. and S. P. Tong, et al. (1993). "Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region." J Virol 67(9): 5402-10.
Tong, S. P. and J. S. Li, et al. (1992). "Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal." Virology 191(1): 237-45.
Li, J. and S. Tong, et al. (1992). "Sequence analysis of PCR amplified hepatitis C virus cDNA from French non-A, non-B hepatitis patients." Arch Virol Suppl 4: 184-5.
Tong, S. and C. Diot, et al. (1992). "Replication of a molecularly cloned HBeAg negative hepatitis B virus variant in transfected HepG2 cells." Arch Virol Suppl 4: 90-4.
Hantz, O. and I. Baginski, et al. (1992). "Viral spliced RNA are produced, encapsidated and reverse transcribed during in vivo woodchuck hepatitis virus infection." Virology 190(1): 193-200.
Bouffard, P. and J. P. Lamelin, et al. (1992). "Phytohemagglutinin and concanavalin A activate hepatitis B virus in peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection." J Med Virol 37(4): 255-62.
Laurent, F. and J. S. Li, et al. (1992). "[Importance of PCR in the diagnosis of hepatitis C]." Rev Fr Transfus Hemobiol 35(3): 211-24.
Fourel, I. and J. Li, et al. (1992). "Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks." J Med Virol 37(2): 122-6.
Zoulim, F. and L. Mimms, et al. (1992). "New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection." J Clin Microbiol 30(5): 1111-9.
Baginski, I. and I. Chemin, et al. (1992). "Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis." Transfusion 32(3): 215-20.
Chemin, I. and I. Baginski, et al. (1992). "Demonstration of woodchuck hepatitis virus infection of peripheral blood mononuclear cells by flow cytometry and polymerase chain reaction." J Gen Virol 73 ( Pt 1): 123-9.
Gaudin, J. L. and X. Causse, et al. (1992). "[Recovery of chronic hepatitis B- delta infection by zidovudine and recombinant interferon alpha combination therapy in a patient with Kaposi's sarcoma associated with HIV infection]." Gastroenterol Clin Biol 16(5): 468-72.
Tong, S. P. and L. Vitvitski, et al. (1992). "Lack of pre-C region mutation in woodchuck hepatitis virus from seroconverted woodchucks." Arch Virol Suppl 4: 95-6.
Li, J. and L. Vitvitski, et al. (1992). "PCR detection of HCV RNA among French non-A, non-B hepatitis patients." Arch Virol Suppl 4: 234-7.
Tong, S. P. and J. S. Li, et al. (1991). "Generation of a 1.5-kb cDNA fragment of the hepatitis C virus genome by overlap extension." J Med Virol 35(4): 228-31.
Lambert, V. and S. Chassot, et al. (1991). "In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein." Virology 185(1): 446-50.
Li, J. S. and S. P. Tong, et al. (1991). "Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain." Gene 105(2): 167-72.
Trepo, C. and P. Opolon, et al. (1991). "[Practical approach to the discovery of serum markers for infection by hepatitis  B virus (HBs antigen or anti HBc antibody). Hypertransaminasemia or the two anomalies in a blood donor]." Rev Fr Transfus Hemobiol 34(4): 285-94.
Li, J. S. and I. Fourel, et al. (1991). "Decreased replication capacity of a duck hepatitis B virus mutant with altered distal pre-S region." Virus Res 20(1): 11-21.
Baginski, I. and I. Chemin, et al. (1991). "Detection of polyadenylated RNA in hepatitis B virus-infected peripheral blood mononuclear cells by polymerase chain reaction." J Infect Dis 163(5): 996-1000.
Tong, S. P. and J. S. Li, et al. (1991). "Rapid screening for bacterial colonies harbouring tandem hepatitis B virus sequences by an oligonucleotide probe." J Virol Methods 32(1): 109-14.
Tong, S. P. and C. Diot, et al. (1991). "In vitro replication competence of a cloned hepatitis B virus variant with a nonsense mutation in the distal pre-C region." Virology 181(2): 733-7.
Krawitt, E. L. and A. Zannier, et al. (1991). "Expression of HLA antigens and T cell infiltrates in chronic viral hepatitis. A comparison of biopsy and fine-needle aspiration findings." J Hepatol 12(2): 190-4.
Lambert, V. and L. Cova, et al. (1991). "Natural and experimental infection of wild mallard ducks with duck hepatitis B virus." J Gen Virol 72 ( Pt 2): 417-20.
Chemin, I. and I. Baginski, et al. (1991). "Correlation between HBV DNA detection by polymerase chain reaction and Pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infections." J Med Virol 33(1): 51-7.
Trepo, C. and P. Rougier, et al. (1991). "Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study." J Hepatol 13 Suppl 1: S3.
Tong, S. P. and B. Brotman, et al. (1991). "In vitro and in vivo replication capacity of the precore region defective hepatitis B virus variants." J Hepatol 13 Suppl 4: S68-73.
Li, J. S. and S. P. Tong, et al. (1991). "Evidence of two major genotypes of hepatitis C virus in France and close relatedness of the predominant one with the prototype virus." J Hepatol 13 Suppl 4: S33-7.
Trepo, C. (1990). "[Hepatitis virus C: from discovery to applications in public health]." Rev Prat 40(18): 1631-9.
Cova, L. and C. P. Wild, et al. (1990). "Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of  liver tumors in ducks." Cancer Res 50(7): 2156-63.
Fourel, I. and O. Hantz, et al. (1990). "Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks." Antimicrob Agents Chemother 34(3): 473-5.
Lambert, V. and D. Fernholz, et al. (1990). "Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein." J Virol 64(3): 1290-7.
Lamelin, J. P. and C. Trepo (1990). "The hepatitis B virus and the peripheral blood mononuclear cells: a brief review." J Hepatol 10(1): 120-4.
Zoulim, F. and J. P. Lamelin, et al. (1990). "[Clinical implications of interactions between hepatitis B virus and mononuclear  leukocytes]." Gastroenterol Clin Biol 14(3): 255-62.
Trepo, C. (1990). "[From non-A non-B hepatitis to hepatitis C virus]." Gastroenterol Clin Biol 14(1): 51-3.
Vitvitski-Trepo, L. and A. Kay, et al. (1990). "Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection." Hepatology 12(6): 1278-83.
Trepo, C. and A. M. Courouce, et al. (1990). "[Discovery of the hepatitis C virus]." Presse Med 19(34): 1582-6.
Trepo, C. and X. Causse (1990). "[Treatment of chronic hepatitis caused by C and non-A, non-B virus (NANB)]." Rev Fr Transfus Hemobiol 33(5): 343-6.
Li, J. and S. Tong, et al. (1990). "Rapid detection and further characterization of infection with hepatitis B virus  variants containing a stop codon in the distal pre-C region." J Gen Virol 71 ( Pt 9): 1993-8.
Bouffard, P. and J. P. Lamelin, et al. (1990). "Different forms of hepatitis B virus DNA and expression of HBV antigens in peripheral blood mononuclear cells in chronic hepatitis B." J Med Virol 31(4): 312-7.
Tong, S. P. and J. S. Li, et al. (1990). "Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region." Virology 176(2): 596-603.
Li, J. S. and L. Cova, et al. (1989). "Duck hepatitis B virus can tolerate insertion, deletion, and partial frameshift mutation in the distal pre-S region." J Virol 63(11): 4965-8.
Zoulim, F. and L. Vitvitski, et al. (1989). "[Significance of the expression of pre-S proteins in mononuclear blood cells in chronic hepatitis caused by the hepatitis B virus]." Gastroenterol Clin Biol 13(8-9): 707-11.
Favre, O. and J. P. Heyraud, et al. (1989). "[Influence of HIV infection on hepatitis B virus infection in homosexual patients]." Gastroenterol Clin Biol 13(8-9): 696-700.
Fourel, I. and P. Gripon, et al. (1989). "Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing." Hepatology 10(2): 186-91.
Trepo, C. (1989). "[Hepatitis B virus and periarteritis nodosa]." Gastroenterol Clin Biol 13(2): 117-9.
Trepo, C. and D. Ouzan, et al. (1988). "[Superiority of a new etiopathogenic treatment curing periarteritis nodosa caused by hepatitis B virus, using a combination of brief corticotherapy, vidarabine and plasma exchange]." Presse Med 17(30): 1527-31.
Fourel, I. and O. Hantz, et al. (1987). "Main properties of duck hepatitis B virus DNA polymerase: comparison with the human and woodchuck hepatitis B virus DNA polymerases." Antiviral Res 8(4): 189-99.
Desgranges, C. and J. Paire, et al. (1987). "High affinity human monoclonal antibodies directed against hepatitis B surface antigen." J Virol Methods 16(4): 281-92.